Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
105726027 | 10572602 | 7 | F | 20140411 | 20160823 | 20141110 | 20160830 | EXP | DE-ROCHE-1406183 | ROCHE | 62.60 | YR | F | Y | 71.00000 | KG | 20160830 | MD | DE | DE |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
105726027 | 10572602 | 1 | PS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | 125085 | 360 | MG | SOLUTION FOR INFUSION | QOW | |||||||
105726027 | 10572602 | 2 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | 125085 | 360 | MG | SOLUTION FOR INFUSION | QOW | |||||||
105726027 | 10572602 | 3 | SS | IRINOTECAN | IRINOTECAN | 1 | Intravenous (not otherwise specified) | SUBSEQUENT DOSES ON 10/APR/2014, 23/APR/2014 AND ON 07/MAY/2014 | 0 | 300 | MG | QOW | |||||||
105726027 | 10572602 | 4 | SS | IRINOTECAN | IRINOTECAN | 1 | Intravenous (not otherwise specified) | 225 MG ?SUBSEQUENT DOSES ON 11/JUN/2014, 25/JUN/2014, 16/JUL/2014, 30/JUL/2014, 13/AUG/2014 AND ON 2 | 0 | 133 | MG/M**2 | QOW | |||||||
105726027 | 10572602 | 5 | SS | 5-FU | FLUOROURACIL | 1 | Intravenous bolus | SUBSEQUENT DOSES ON 10/APR/2014 AND ON 23/APR/2014 | 0 | 680 | MG | ||||||||
105726027 | 10572602 | 6 | SS | 5-FU | FLUOROURACIL | 1 | Intravenous bolus | 0 | 500 | MG | QOW | ||||||||
105726027 | 10572602 | 7 | SS | 5-FU | FLUOROURACIL | 1 | Intravenous bolus | SUBSEQUENT DOSES ON 11/JUN/2014, 25/JUN/2014, 16/JUL/2014, 30/JUL/2014, 13/AUG/2014 AND ON 27/AUG/20 | 0 | 450 | MG | QOW | |||||||
105726027 | 10572602 | 8 | SS | 5-FU | FLUOROURACIL | 1 | Intravenous (not otherwise specified) | 0 | 4080 | MG | INFUSION | QOW | |||||||
105726027 | 10572602 | 9 | SS | 5-FU | FLUOROURACIL | 1 | Intravenous (not otherwise specified) | 0 | 4080 | MG | INFUSION | QOW | |||||||
105726027 | 10572602 | 10 | SS | 5-FU | FLUOROURACIL | 1 | Intravenous (not otherwise specified) | 0 | 4080 | MG | INFUSION | QOW | |||||||
105726027 | 10572602 | 11 | SS | 5-FU | FLUOROURACIL | 1 | Intravenous (not otherwise specified) | 0 | 3000 | MG | INFUSION | QOW | |||||||
105726027 | 10572602 | 12 | SS | 5-FU | FLUOROURACIL | 1 | Intravenous (not otherwise specified) | 0 | 2700 | MG | INFUSION | QOW | |||||||
105726027 | 10572602 | 13 | SS | 5-FU | FLUOROURACIL | 1 | Intravenous (not otherwise specified) | 0 | 2700 | MG | INFUSION | QOW | |||||||
105726027 | 10572602 | 14 | SS | 5-FU | FLUOROURACIL | 1 | Intravenous (not otherwise specified) | 0 | 2700 | MG | INFUSION | QOW | |||||||
105726027 | 10572602 | 15 | SS | 5-FU | FLUOROURACIL | 1 | Intravenous (not otherwise specified) | 0 | 2700 | MG | INFUSION | QOW | |||||||
105726027 | 10572602 | 16 | SS | 5-FU | FLUOROURACIL | 1 | Intravenous (not otherwise specified) | 0 | 2700 | MG | INFUSION | QOW | |||||||
105726027 | 10572602 | 17 | SS | 5-FU | FLUOROURACIL | 1 | Intravenous (not otherwise specified) | 0 | 2700 | MG | INFUSION | QOW | |||||||
105726027 | 10572602 | 18 | SS | 5-FU | FLUOROURACIL | 1 | Intravenous (not otherwise specified) | 0 | 2700 | MG | INFUSION | QOW | |||||||
105726027 | 10572602 | 19 | SS | 5-FU | FLUOROURACIL | 1 | Intravenous bolus | 450-680MG | 0 | QOW | |||||||||
105726027 | 10572602 | 20 | C | DEXAMETHASON | DEXAMETHASONE | 1 | Intravenous (not otherwise specified) | 0 | 8 | MG | QOW | ||||||||
105726027 | 10572602 | 21 | C | DEXAMETHASON | DEXAMETHASONE | 1 | 0 | ||||||||||||
105726027 | 10572602 | 22 | C | ONDANSETRON | ONDANSETRON | 1 | Intravenous (not otherwise specified) | 0 | 8 | MG | QOW | ||||||||
105726027 | 10572602 | 23 | C | ONDANSETRON | ONDANSETRON | 1 | 0 | ||||||||||||
105726027 | 10572602 | 24 | C | FOLINIC ACID | LEUCOVORIN | 1 | Intravenous (not otherwise specified) | 0 | 852.42 | MG | QOW | ||||||||
105726027 | 10572602 | 25 | C | FOLINIC ACID | LEUCOVORIN | 1 | Intravenous (not otherwise specified) | 0 | 400 | MG | QOW | ||||||||
105726027 | 10572602 | 26 | C | FOLINIC ACID | LEUCOVORIN | 1 | Intravenous (not otherwise specified) | 0 | 400 | MG | QOW | ||||||||
105726027 | 10572602 | 27 | C | FOLINIC ACID | LEUCOVORIN | 1 | Intravenous (not otherwise specified) | 0 | 400 | MG | QOW | ||||||||
105726027 | 10572602 | 28 | C | FOLINIC ACID | LEUCOVORIN | 1 | Intravenous (not otherwise specified) | 0 | 400 | MG | QOW | ||||||||
105726027 | 10572602 | 29 | C | FOLINIC ACID | LEUCOVORIN | 1 | Intravenous (not otherwise specified) | 0 | 400 | MG | QOW | ||||||||
105726027 | 10572602 | 30 | C | FOLINIC ACID | LEUCOVORIN | 1 | Intravenous (not otherwise specified) | 0 | 400 | MG | QOW | ||||||||
105726027 | 10572602 | 31 | C | FOLINIC ACID | LEUCOVORIN | 1 | Intravenous (not otherwise specified) | 0 | 400 | MG | QOW | ||||||||
105726027 | 10572602 | 32 | C | FOLINIC ACID | LEUCOVORIN | 1 | Intravenous (not otherwise specified) | 0 | 400 | MG | QOW | ||||||||
105726027 | 10572602 | 33 | C | FOLINIC ACID | LEUCOVORIN | 1 | Intravenous (not otherwise specified) | 0 | 400 | MG | QOW | ||||||||
105726027 | 10572602 | 34 | C | FOLINIC ACID | LEUCOVORIN | 1 | Intravenous (not otherwise specified) | 0 | 400 | MG | QOW | ||||||||
105726027 | 10572602 | 35 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | Oral | 0 | 6.25 | MG | QD | ||||||||
105726027 | 10572602 | 36 | C | CANDESARTAN | CANDESARTAN | 1 | Oral | 0 | 16 | MG | QD | ||||||||
105726027 | 10572602 | 37 | C | PREDNISOLONE. | PREDNISOLONE | 1 | Oral | 0 | 5 | MG | QD | ||||||||
105726027 | 10572602 | 38 | C | METHOTREXATE. | METHOTREXATE | 1 | Unknown | 0 | 15 | MG | |||||||||
105726027 | 10572602 | 39 | C | DOXEPIN | DOXEPIN | 1 | Oral | 0 | 5 | MG | QD | ||||||||
105726027 | 10572602 | 40 | C | FENTANYL. | FENTANYL | 1 | Unknown | PRO HOUR | 0 | 75 | UG | ||||||||
105726027 | 10572602 | 41 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Oral | 0 | 40 | MG | QD | ||||||||
105726027 | 10572602 | 42 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Oral | 0 | 40 | MG | BID | ||||||||
105726027 | 10572602 | 43 | C | METAMIZOL | METAMIZOLE SODIUM | 1 | Oral | 0 | 20 | GTT | QID | ||||||||
105726027 | 10572602 | 44 | C | METAMIZOL | METAMIZOLE SODIUM | 1 | Oral | 0 | 40 | GTT | QID | ||||||||
105726027 | 10572602 | 45 | C | VALSARTAN. | VALSARTAN | 1 | Oral | 0 | 80 | MG | QD | ||||||||
105726027 | 10572602 | 46 | C | SODIUM PICOSULFATE | SODIUM PICOSULFATE | 1 | Oral | 0 | |||||||||||
105726027 | 10572602 | 47 | C | BENZYDAMINE | BENZYDAMINE | 1 | Oral | 0 | 15 | ML | QID | ||||||||
105726027 | 10572602 | 48 | C | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | Oral | 0 | 20 | GTT | TID | ||||||||
105726027 | 10572602 | 49 | C | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | Oral | 0 | 10 | MG | TID | ||||||||
105726027 | 10572602 | 50 | C | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | Oral | 0 | 30 | MG | BID | ||||||||
105726027 | 10572602 | 51 | C | LOPERAMID | LOPERAMIDE | 1 | Oral | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
105726027 | 10572602 | 1 | Colorectal cancer |
105726027 | 10572602 | 3 | Colorectal cancer |
105726027 | 10572602 | 5 | Colorectal cancer |
105726027 | 10572602 | 20 | Vomiting |
105726027 | 10572602 | 21 | Nausea |
105726027 | 10572602 | 22 | Vomiting |
105726027 | 10572602 | 23 | Prophylaxis of nausea and vomiting |
105726027 | 10572602 | 24 | Colorectal cancer |
105726027 | 10572602 | 35 | Hypertension |
105726027 | 10572602 | 36 | Hypertension |
105726027 | 10572602 | 37 | Rheumatoid arthritis |
105726027 | 10572602 | 38 | Rheumatoid arthritis |
105726027 | 10572602 | 39 | Depression |
105726027 | 10572602 | 40 | Analgesic therapy |
105726027 | 10572602 | 41 | Abdominal discomfort |
105726027 | 10572602 | 43 | Analgesic therapy |
105726027 | 10572602 | 45 | Hypertension |
105726027 | 10572602 | 46 | Constipation |
105726027 | 10572602 | 47 | Stomatitis |
105726027 | 10572602 | 48 | Prophylaxis of nausea and vomiting |
105726027 | 10572602 | 51 | Diarrhoea |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
105726027 | 10572602 | DE |
105726027 | 10572602 | HO |
105726027 | 10572602 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
105726027 | 10572602 | Abdominal pain | |
105726027 | 10572602 | Ascites | |
105726027 | 10572602 | Decreased appetite | |
105726027 | 10572602 | Dehydration | |
105726027 | 10572602 | Diarrhoea | |
105726027 | 10572602 | General physical health deterioration | |
105726027 | 10572602 | Hepatic failure | |
105726027 | 10572602 | Hepatic function abnormal | |
105726027 | 10572602 | Nausea | |
105726027 | 10572602 | Palmar-plantar erythrodysaesthesia syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
105726027 | 10572602 | 1 | 20140327 | 0 | ||
105726027 | 10572602 | 2 | 20140827 | 0 | ||
105726027 | 10572602 | 3 | 20140327 | 0 | ||
105726027 | 10572602 | 4 | 20140528 | 0 | ||
105726027 | 10572602 | 5 | 20140327 | 0 | ||
105726027 | 10572602 | 6 | 20140507 | 0 | ||
105726027 | 10572602 | 7 | 20140528 | 0 | ||
105726027 | 10572602 | 8 | 20140327 | 20140329 | 0 | |
105726027 | 10572602 | 9 | 20140410 | 20140412 | 0 | |
105726027 | 10572602 | 10 | 20140423 | 20140425 | 0 | |
105726027 | 10572602 | 11 | 20140507 | 20140509 | 0 | |
105726027 | 10572602 | 12 | 20140528 | 20140530 | 0 | |
105726027 | 10572602 | 13 | 20140611 | 20140613 | 0 | |
105726027 | 10572602 | 14 | 20140625 | 20140627 | 0 | |
105726027 | 10572602 | 15 | 20140716 | 20140718 | 0 | |
105726027 | 10572602 | 16 | 20140730 | 20140801 | 0 | |
105726027 | 10572602 | 17 | 20140813 | 20140815 | 0 | |
105726027 | 10572602 | 18 | 20140827 | 20140829 | 0 | |
105726027 | 10572602 | 19 | 20140327 | 20140827 | 0 | |
105726027 | 10572602 | 20 | 20140327 | 0 | ||
105726027 | 10572602 | 22 | 20140327 | 0 | ||
105726027 | 10572602 | 24 | 20140327 | 20140327 | 0 | |
105726027 | 10572602 | 25 | 20140410 | 20140410 | 0 | |
105726027 | 10572602 | 26 | 20140423 | 20140423 | 0 | |
105726027 | 10572602 | 27 | 20140507 | 20140507 | 0 | |
105726027 | 10572602 | 28 | 20140528 | 20140528 | 0 | |
105726027 | 10572602 | 29 | 20140611 | 20140611 | 0 | |
105726027 | 10572602 | 30 | 20140626 | 20140626 | 0 | |
105726027 | 10572602 | 31 | 20140716 | 20140716 | 0 | |
105726027 | 10572602 | 32 | 20140730 | 20140730 | 0 | |
105726027 | 10572602 | 33 | 20140813 | 20140813 | 0 | |
105726027 | 10572602 | 34 | 20140827 | 20140827 | 0 | |
105726027 | 10572602 | 36 | 20140923 | 0 | ||
105726027 | 10572602 | 38 | 201403 | 0 | ||
105726027 | 10572602 | 41 | 20140320 | 20140707 | 0 | |
105726027 | 10572602 | 42 | 20140708 | 0 | ||
105726027 | 10572602 | 43 | 20140524 | 20140707 | 0 | |
105726027 | 10572602 | 44 | 20140708 | 0 | ||
105726027 | 10572602 | 45 | 20140924 | 0 | ||
105726027 | 10572602 | 46 | 20140410 | 201404 | 0 | |
105726027 | 10572602 | 47 | 20140423 | 20140507 | 0 | |
105726027 | 10572602 | 48 | 20140326 | 20140523 | 0 | |
105726027 | 10572602 | 49 | 20140524 | 20140607 | 0 | |
105726027 | 10572602 | 50 | 20140708 | 0 | ||
105726027 | 10572602 | 51 | 20140528 | 0 |